Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review H1 2015


#308804

105pages

GlobalData

$ 2500

In Stock

Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2015" provides an overview of Reflux Esophagitis (Gastroesophageal Reflux Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Reflux Esophagitis (Gastroesophageal Reflux Disease) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Datas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 7
Reflux Esophagitis (Gastroesophageal Reflux Disease) 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Unaccomplished Trials of Reflux Esophagitis (Gastroesophageal Reflux Disease) 26
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials 34
Prominent Drugs 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
AstraZeneca Plc 36
Clinical Trial Overview of AstraZeneca Plc 36
Takeda Pharmaceutical Company Limited 43
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 43
Eisai Co., Ltd. 48
Clinical Trial Overview of Eisai Co., Ltd. 48
Johnson & Johnson 51
Clinical Trial Overview of Johnson & Johnson 51
Janssen Global Services, LLC 53
Clinical Trial Overview of Janssen Global Services, LLC 53
Indivior Plc 55
Clinical Trial Overview of Indivior Plc 55
Pfizer Inc. 57
Clinical Trial Overview of Pfizer Inc. 57
Novartis AG 58
Clinical Trial Overview of Novartis AG 58
Yuhan Corporation 59
Clinical Trial Overview of Yuhan Corporation 59
Dr. Reddy's Laboratories Limited 60
Clinical Trial Overview of Dr. Reddy's Laboratories Limited 60
Clinical Trial Overview of Top Institutes / Government 61
Shimane University 61
Clinical Trial Overview of Shimane University 61
Mayo Clinic 62
Clinical Trial Overview of Mayo Clinic 62
Academic Medical Center 63
Clinical Trial Overview of Academic Medical Center 63
Juntendo University School of Medicine 64
Clinical Trial Overview of Juntendo University School of Medicine 64
Seoul National University Hospital 65
Clinical Trial Overview of Seoul National University Hospital 65
Yokohama City University 66
Clinical Trial Overview of Yokohama City University 66
General Public Hospital Zell am See 67
Clinical Trial Overview of General Public Hospital Zell am See 67
Guy's and St Thomas' NHS Foundation Trust 68
Clinical Trial Overview of Guy's and St Thomas' NHS Foundation Trust 68
Hospital Authority 69
Clinical Trial Overview of Hospital Authority 69
National Taiwan University Hospital 70
Clinical Trial Overview of National Taiwan University Hospital 70
Five Key Clinical Profiles 71
Appendix 102
Abbreviations 102
Definitions 102
Research Methodology 103
Secondary Research 103
About GlobalData 104
Contact Us 104
Disclaimer 104
Source 105

List of Tables
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Region, 2015* 8
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 9
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 10
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 11
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 12
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, North America, Top Countries, 2015* 13
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 14
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 15
Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 16
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18
Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 19
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 20
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 21
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Phase, 2015* 22
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 23
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 24
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 25
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Suspended Clinical Trials, 2015* 26
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Withdrawn Clinical Trials, 2015* 27
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Terminated Clinical Trials, 2015* 28
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 31
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 32
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 33
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 34
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 35
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015* 36
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 43
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 48
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 51
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Global Services, LLC, 2015* 53
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Indivior Plc, 2015* 55
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 57
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 58
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Yuhan Corporation, 2015* 59
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Reddy's Laboratories Limited, 2015* 60
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shimane University, 2015* 61
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 62
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 63
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University School of Medicine, 2015* 64
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 65
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University, 2015* 66
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by General Public Hospital Zell am See, 2015* 67
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Guy's and St Thomas' NHS Foundation Trust, 2015* 68
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Authority, 2015* 69
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2015* 70

List of Figures
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Region (%), 2015* 8
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 9
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 10
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 11
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 12
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 13
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 14
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 15
Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 16
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18
Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 19
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 20
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 21
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 22
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 23
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 24
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 25
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 31
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 32
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 33
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 34
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 35
GlobalData Methodology 103